Ergomed

Ergomed is a global leader in specialized clinical research services, operating with a footprint in around 100 countries and supported by 2,900+ experienced professionals worldwide. Founded in 1997, the company provides comprehensive solutions for the most demanding clinical projects, specializing in oncology, rare diseases, and complex clinical trials for pharmaceutical and biotechnology industries. Ergomed has conducted 330+ oncology studies and 200+ rare disease trials, demonstrating deep therapeutic expertise and unrivaled capability in these challenging areas.

Through its specialized subsidiaries - Ergomed Clinical Research, PrimeVigilance, and ADAMAS Consulting - the group delivers end-to-end clinical development, pharmacovigilance, and GxP audit services. The company's proprietary Ergomed CARE™ solution ensures patient-centric trial management, while its flat organizational structure enables unmatched agility and responsiveness. Ergomed has managed over 600 Phase I-IV clinical trials and processed 275,000+ patient cases annually, maintaining a global headquarters in Guildford, UK, and US headquarters in Raleigh, NC.